| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | $141.25M | - | |
| Dir | 161.6K | $57.35M | - | |
| Other | 99.6K | $35.37M | - | |
| Dir | 83.7K | $29.72M | - | |
| Dir | 73.2K | $25.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | John Oyler58 | Chief Executive Officer | Sale+OE | 101,000 | $244.30 | $24,674,638.28 | - | +0.2% | +21.0% | |
| Feb 28, 2025 | Baker Bros. Advisors LP61 | Director | Sell | 732,827 | $260.00 | $190,535,020.00 | -8.3% | -9.2% | +16.5% | |
| Feb 28, 2025 | Xiaobin Wu52 | President, COO & Gm China | Sell | 0 | $0.00 | - | New | -9.2% | +16.5% | |
| Feb 27, 2025 | Chan Henry Lee49 | SVP, General Counsel | Sell10b5-1 | 1,205 | $275.00 | $331,375.00 | -100% | -13.6% | +13.8% | |
| Feb 21, 2025 | Chan Henry Lee49 | SVP, General Counsel | Sell10b5-1 | 1,202 | $258.04 | $310,169.72 | -100% | -6.5% | +41.8% | |
| Feb 21, 2025 | Lai Wang50 | Global Head of R& D | Sell10b5-1 | 5,000 | $257.23 | $1,286,174.03 | -100% | -6.5% | +41.8% | |
| Feb 20, 2025 | Xiaobin Wu52 | President, COO & Gm China | Sale+OE10b5-1 | 51,921 | $240.46 | $12,485,044.71 | - | -3.2% | +48.3% | |
| Feb 4, 2025 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 41,760 | $225.69 | $9,424,955.38 | - | +14.0% | +57.9% | |
| Jan 7, 2025 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 41,760 | $176.50 | $7,370,514.66 | - | +26.0% | +90.7% | |
| Dec 10, 2024 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 41,760 | $186.90 | $7,805,105.81 | - | +29.4% | +72.1% |